Presented at the 2025 American Society for Metabolic and Bariatric Surgery Annual Meeting, June 15-19 in Washington, D.C., this study examined symptom outcomes following hiatal hernia repair in patients who previously underwent Roux-en-Y gastric bypass, highlighting significant postoperative symptom improvement.
The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC)…
In a phase 3 trial, tolebrutinib, an oral Bruton’s tyrosine kinase inhibitor, significantly reduced the risk of sustained disability progression in patients with nonrelapsing secondary…
In his presentation at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, Scott Pritzlaff, MD, reviewed how modalities like MRI,…
Robotic surgery significantly reduced the 3-year locoregional recurrence rate and improved disease-free survival in patients with middle or low rectal cancer compared with conventional laparoscopic…
For patients with type 2 diabetes and established cardiovascular or kidney disease, daily oral semaglutide significantly lowered the risk of major adverse cardiovascular events during…
A national analysis of county-level measles-mumps-rubella vaccination rates from 2017 to 2024 shows a significant decline following the COVID-19 pandemic, with geographic variation and implications…
Want to Peer Review for Consultant? We would welcome your involvement! Please send a short email to the editorial office summarizing your areas of expertise and qualifications to our…
A phase 3b trial evaluated as-needed albuterol–budesonide versus albuterol alone in patients with uncontrolled mild asthma.
Nerve blocks administered in the emergency department significantly reduce opioid use in patients with hip fractures, but their effectiveness may wane within 36 hours—before most…
